Business
Avricore Health Announces $1.25 Million Financing
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes. Each Unit consists of one common share and one half transferrable share purchase warrant. Each
About this update from Avricore Health Inc.
[{"type":"image","alt":"Avricore Health Inc.","displaySize":"","headline":null,"caption":"Avricore Health Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":101,"url":"https://media.zenfs.com/en/globenewswire.com/c0da71ca0c3b0e4707187cbddf04634c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jJCO1_joYAZvaikg.RL39w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MQ--/https://media.zenfs.com/en/globenewswire.com/c0da71ca0c3b0e4707187cbddf04634c","width":300,"height":101},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/jJCO1_joYAZvaikg.RL39w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MQ--/https://media.zenfs.com/en/globenewswire.com/c0da71ca0c3b0e4707187cbddf04634c","width":300,"height":101}},"lazy":false},{"type":"text","content":"VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price of $0.05 per unit for gross proceeds of $1,250,000. (the "Private Placement"). The proceeds will be used to expand the Company’s HealthTab™ network and for general working capital purposes.","length":440,"tagName":"p"},{"type":"text","content":"Each Unit consists of one common share and one half transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the closing date of the offering at a price of $0.10 per common share. The Company may pay finders fees of up to 7% cash and 7% brokers warrants on a portion of the placement. Each broker warrant will entitle the holder thereof to purchase one additional common share for a period of 24 months from the closing date of the offering at a price of $0.05 per common share.","length":575,"tagName":"p"},{"type":"text","content":"The Offering is available to accredited investors as well as all shareholders of record of the Company as at May 19, 2026 (the "Record Date") resident in Canada who are eligible to participate under the exemption from prospectus requirements set out in applicable instruments of Canadian Securities Administrators (the “Existing Shareholder Exemption”) and who continue to be shareholders of the Company immediately prior to the closing of the Offering.","length":463,"tagName":"p"},{...